Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).
| Image |  |
|---|---|
| Description | scientific article published on June 2007 |
| Author/s |
author: Margaret A Fischl Ann C Collier Cecilia M Shikuma Kevin Yarasheski Pablo Tebas |
| Publication date | June 1, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |